Header Logo

Connection

Douglas Corley to Esophagogastric Junction

This is a "connection" page, showing publications Douglas Corley has written about Esophagogastric Junction.
Connection Strength

0.531
  1. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction. Am J Gastroenterol. 2021 05 01; 116(5):949-957.
    View in: PubMed
    Score: 0.194
  2. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012 Mar; 142(3):442-452.e5; quiz e22-3.
    View in: PubMed
    Score: 0.101
  3. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010 Sep 08; 102(17):1344-53.
    View in: PubMed
    Score: 0.092
  4. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010 Jul; 46(11):2067-76.
    View in: PubMed
    Score: 0.090
  5. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012 Dec; 41(6):1706-18.
    View in: PubMed
    Score: 0.027
  6. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol. 2012 Jun; 36(3):306-16.
    View in: PubMed
    Score: 0.026

© 2024 Kaiser Permanente